ArticleSovremennye tekhnologii v meditsine2026
Russian‑Language Version of the Trail Making Test Implemented on the Inquisit Computer Platform.
Article in Sovremennye tekhnologii v meditsine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Materials and Methods: A total of 69 individuals were examined: 34 conditionally mentally healthy volunteers (12 men and 22 women; mean age 20.6 [20.1; 21.2] years) and 35 schizophrenia patients (12 men and 23 women; mean age 38.7 [34.1; 43.3] years). The test tasks and user interface of the original English‑language TMT script were translated into Russian. The correctness of the translation was verified by the Inquisit platform developers, after which the Russian‑language version was made available on the platform. The study (testing was performed twice) was conducted using the Russian‑language TMT script, the Cancellation Test, the Number Finding Test (Schulte tables), and the 10‑Word Learning Test. Results: Cronbach's alpha coefficient was 0.96 for the conditionally mentally healthy group and 0.90 for the schizophrenia patient group, indicating sufficient internal consistency of the TMT. Quantitative measures of test‑retest reliability reached noticeable to high levels on the Chaddock scale for time‑based parameters, while no correlations were found for the number of errors. For both groups, positive statistically significant correlations were found between the time spent on the TMT and the Number Finding Test. In the schizophrenia patients, negative statistically significant correlations were found between the number of lines processed (Cancellation Test) and the time spent (TMT). These findings confirm convergent validity between TMT time scores, classical attention tests, and dynamic characteristics of thinking. At the same time, no significant correlations were found between the number of errors in the TMT and in the Cancellation Test. This might be related to different neuropsychological mechanisms underlying errors in these tests. Discriminant validity was demonstrated by the absence of significant correlations between most TMT measures and the results of the 10‑Word Learning Test in both groups. Conclusion: The adapted TMT has sufficient internal consistency, convergent and discriminant validity, and test‑retest reliability. Thus, it can be recommended for use in research to assess executive function deficits in schizophrenia patients. Notably, time spent on TMT tasks is the parameter that most closely corresponds to the assessment of dynamic attention indicators.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.